FYN is downstream of the HGF/MET signaling loop, and HGF can effectively regulate FYN activity, which promotes prostate cancer biology by promoting cell growth and regulating targeted chemotaxis-translocation components in prostate cancer biology [59]. The gene discussed is MET; the disease is prostate carcinoma.